See more : The Monarch Cement Company (MCEM) Income Statement Analysis – Financial Results
Complete financial analysis of National Health Investors, Inc. (NHI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of National Health Investors, Inc., a leading company in the REIT – Healthcare Facilities industry within the Real Estate sector.
You may be interested
- FFBW, Inc. (FFBW) Income Statement Analysis – Financial Results
- Bintulu Port Holdings Berhad (5032.KL) Income Statement Analysis – Financial Results
- Ban Loong Holdings Limited (0030.HK) Income Statement Analysis – Financial Results
- QL Resources Berhad (7084.KL) Income Statement Analysis – Financial Results
- First Light Acquisition Group, Inc. (FLAG) Income Statement Analysis – Financial Results
National Health Investors, Inc. (NHI)
About National Health Investors, Inc.
Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 319.84M | 278.19M | 298.72M | 332.81M | 318.08M | 294.61M | 278.66M | 248.50M | 228.99M | 177.51M | 117.83M | 96.95M | 82.70M | 78.40M | 64.22M | 63.01M | 62.31M | 150.72M | 157.38M | 155.56M | 162.49M | 171.78M | 139.17M | 147.51M | 131.16M | 102.29M | 110.18M | 99.43M | 87.90M | 71.40M | 49.50M | 39.40M | 7.90M |
| Cost of Revenue | 11.51M | 9.79M | 11.64M | 9.65M | 5.80M | 1.17M | 960.00K | 1.01M | 985.00K | 620.00K | 616.00K | 771.00K | 0.00 | 2.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 308.32M | 268.41M | 287.08M | 323.16M | 312.28M | 293.45M | 277.70M | 247.49M | 228.00M | 176.89M | 117.21M | 96.18M | 82.70M | 76.39M | 64.22M | 63.01M | 62.31M | 150.72M | 157.38M | 155.56M | 162.49M | 171.78M | 139.17M | 147.51M | 131.16M | 102.29M | 110.18M | 99.43M | 87.90M | 71.40M | 49.50M | 39.40M | 7.90M |
| Gross Profit Ratio | 96.40% | 96.48% | 96.10% | 97.10% | 98.18% | 99.60% | 99.66% | 99.59% | 99.57% | 99.65% | 99.48% | 99.20% | 100.00% | 97.44% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Research & Development | 0.00 | 0.23 | 0.38 | 0.57 | 0.50 | 0.52 | 0.58 | 0.65 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 19.72M | 25.32M | 19.34M | 14.56M | 13.91M | 12.86M | 12.71M | 10.20M | 10.98M | 9.32M | 10.04M | 8.57M | 8.03M | 8.85M | 7.21M | 5.18M | 5.66M | 5.34M | 4.31M | 3.49M | 3.14M | 2.43M | 3.30M | 3.46M | 3.28M | 3.89M | 3.70M | 3.69M | 3.40M | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 100.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 19.82M | 25.32M | 19.34M | 14.56M | 13.91M | 12.86M | 12.71M | 10.20M | 10.98M | 9.32M | 10.04M | 8.57M | 8.03M | 8.85M | 7.21M | 5.18M | 5.66M | 5.34M | 4.31M | 3.49M | 3.14M | 2.43M | 3.30M | 3.46M | 3.28M | 3.89M | 3.70M | 3.69M | 3.40M | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 109.71M | 99.92M | 134.35M | 84.68M | 78.37M | 71.35M | 67.17M | 1.66M | 53.16M | 38.08M | 3.31M | 4.85M | 12.81M | 11.05M | 7.37M | 8.55M | 2.36M | 95.15M | 116.67M | 96.24M | 101.89M | 127.25M | 115.83M | 81.79M | 99.86M | 47.87M | 53.31M | 49.21M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 129.53M | 125.24M | 153.69M | 99.23M | 92.27M | 85.37M | 80.84M | 70.77M | 65.13M | 48.01M | 30.76M | 25.92M | 20.84M | 19.90M | 14.58M | 13.73M | 8.01M | 100.50M | 120.98M | 99.73M | 105.03M | 129.67M | 119.13M | 85.25M | 103.14M | 51.76M | 57.01M | 52.90M | -7.60M | -10.50M | -8.20M | -7.10M | -1.60M |
| Cost & Expenses | 143.36M | 135.03M | 165.33M | 108.88M | 98.07M | 85.37M | 80.84M | 70.77M | 65.13M | 48.01M | 30.76M | 25.92M | 20.84M | 19.90M | 14.58M | 13.73M | 8.01M | 100.50M | 120.98M | 99.73M | 105.03M | 129.67M | 119.13M | 85.25M | 103.14M | 51.76M | 57.01M | 52.90M | -7.60M | -10.50M | -8.20M | -7.10M | -1.60M |
| Interest Income | -2.65M | 44.92M | 50.81M | 52.88M | 56.30M | 0.00 | 18.00K | 0.00 | 0.00 | 0.00 | 6.74M | 1.24M | 6.49M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Interest Expense | 55.51M | 44.92M | 50.81M | 52.88M | 56.30M | 49.06M | 43.11M | 9.23M | 3.49M | 3.85M | 1.55M | 85.00K | 308.00K | 4.63M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Depreciation & Amortization | 69.97M | 140.03M | 165.45M | 106.65M | 99.16M | 89.79M | 79.96M | 86.12M | 53.16M | 40.69M | 20.10M | 16.58M | 11.99M | 10.99M | 8.62M | 7.94M | 11.73M | 11.81M | 12.60M | 14.45M | 15.38M | 16.38M | 14.66M | 14.17M | 11.49M | 8.96M | 8.04M | 6.83M | 6.10M | 5.30M | 5.20M | 4.70M | 1.20M |
| EBITDA | 251.49M | 151.99M | 212.99M | 303.95M | 296.83M | 280.59M | 264.99M | 236.08M | 179.36M | 167.06M | 107.63M | 87.66M | 76.05M | 68.15M | 57.57M | 53.34M | 82.87M | 66.31M | 49.38M | 55.29M | 72.84M | 247.76M | 233.19M | 77.60M | 91.44M | 60.18M | 61.21M | 54.48M | 101.60M | 87.20M | 62.90M | 51.20M | 10.70M |
| EBITDA Ratio | 78.63% | 54.64% | 71.30% | 91.33% | 93.32% | 95.24% | 95.09% | 95.00% | 94.00% | 93.17% | 91.23% | 90.42% | 71.48% | 82.01% | 81.52% | 80.51% | 84.55% | 32.83% | 20.37% | 37.71% | 44.83% | 31.39% | 25.71% | 52.61% | 30.69% | 58.83% | 55.55% | 54.79% | 115.59% | 122.13% | 127.07% | 129.95% | 135.44% |
| Operating Income | 178.79M | 81.11M | 132.19M | 220.80M | 220.01M | 209.24M | 197.82M | 177.73M | 163.86M | 106.19M | 77.84M | 71.04M | 61.86M | 58.50M | 49.64M | 49.27M | 54.30M | 50.23M | 36.40M | 55.83M | 57.46M | 42.11M | 20.04M | 62.26M | 28.02M | 50.53M | 53.17M | 46.53M | 95.50M | 81.90M | 57.70M | 46.50M | 9.50M |
| Operating Income Ratio | 55.90% | 29.16% | 44.25% | 66.34% | 69.17% | 71.02% | 70.99% | 71.52% | 71.56% | 59.82% | 66.07% | 73.27% | 74.80% | 74.62% | 77.30% | 78.20% | 87.14% | 33.32% | 23.13% | 35.89% | 35.36% | 24.51% | 14.40% | 42.21% | 21.37% | 49.40% | 48.26% | 46.80% | 108.65% | 114.71% | 116.57% | 118.02% | 120.25% |
| Total Other Income/Expenses | -44.41M | -80.22M | -15.04M | -33.54M | -59.56M | -49.94M | -38.45M | -74.13M | -66.10M | -26.44M | -28.49M | 0.00 | 7.95M | -707.00K | 0.00 | 0.00 | -3.48M | 8.44M | 16.93M | -4.89M | 0.00 | -185.02M | -218.78M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax | 134.38M | 65.50M | 111.97M | 185.31M | 160.45M | 154.33M | 159.37M | 153.47M | 149.61M | 103.05M | 79.50M | 74.66M | 81.13M | 69.42M | 64.23M | 57.51M | 67.64M | 62.95M | 53.71M | 67.52M | 0.00 | 47.19M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax Ratio | 42.02% | 23.55% | 37.48% | 55.68% | 50.44% | 52.39% | 57.19% | 61.76% | 65.33% | 58.05% | 67.47% | 77.01% | 98.10% | 88.55% | 100.01% | 91.28% | 108.55% | 41.76% | 34.13% | 43.41% | 0.00% | 27.47% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 42.44M | 49.78M | 49.94M | 56.29M | -9.17M | 46.32M | 749.00K | -707.00K | 24.67M | -17.13M | -12.53M | -19.27M | -10.92M | -14.59M | -8.24M | -42.13M | -18.83M | -17.65M | -472.00K | 13.66M | 11.83M | 21.19M | 29.70M | -24.85M | -18.42M | -22.22M | -19.52M | 45.80M | 43.00M | 33.30M | 33.20M | 7.40M |
| Net Income | 135.65M | 23.06M | 62.19M | 135.37M | 104.16M | 154.33M | 159.37M | 151.54M | 148.86M | 101.61M | 106.18M | 90.73M | 81.13M | 69.42M | 64.23M | 57.51M | 96.44M | 69.23M | 54.41M | 56.38M | 43.81M | 30.79M | -63.00K | 33.72M | 53.62M | 69.65M | 75.39M | 67.16M | 49.70M | 38.90M | 24.40M | 13.30M | 2.10M |
| Net Income Ratio | 42.41% | 8.29% | 20.82% | 40.67% | 32.75% | 52.39% | 57.19% | 60.98% | 65.01% | 57.24% | 90.12% | 93.58% | 98.10% | 88.55% | 100.01% | 91.28% | 154.76% | 45.93% | 34.57% | 36.24% | 26.96% | 17.92% | -0.05% | 22.86% | 40.88% | 68.08% | 68.42% | 67.55% | 56.54% | 54.48% | 49.29% | 33.76% | 26.58% |
| EPS | 3.13 | 0.52 | 1.36 | 3.03 | 2.40 | 3.68 | 3.90 | 3.88 | 3.96 | 3.04 | 3.74 | 3.26 | 2.93 | 2.51 | 2.33 | 2.08 | 3.48 | 2.50 | 1.96 | 2.05 | 1.58 | 1.10 | 0.00 | 1.31 | 2.13 | 2.72 | 3.01 | 2.92 | 2.63 | 2.35 | 1.95 | 1.60 | 0.29 |
| EPS Diluted | 3.13 | 0.51 | 1.36 | 3.03 | 2.38 | 3.67 | 3.87 | 3.87 | 3.95 | 3.04 | 3.74 | 3.26 | 2.92 | 2.50 | 2.32 | 2.07 | 3.47 | 2.49 | 1.96 | 2.03 | 1.57 | 1.10 | 0.00 | 1.31 | 2.13 | 2.69 | 2.92 | 2.80 | 2.49 | 2.28 | 1.95 | 1.60 | 0.29 |
| Weighted Avg Shares Out | 43.39M | 44.77M | 45.71M | 44.70M | 43.42M | 41.94M | 40.89M | 39.01M | 37.60M | 33.38M | 28.36M | 27.81M | 27.72M | 27.66M | 27.59M | 27.71M | 27.70M | 27.74M | 27.70M | 27.26M | 26.73M | 26.45M | 24.47M | 24.38M | 24.37M | 24.96M | 24.42M | 21.94M | 16.39M | 13.28M | 12.51M | 7.48M | 7.24M |
| Weighted Avg Shares Out (Dil) | 43.39M | 44.79M | 45.73M | 44.70M | 43.70M | 42.09M | 41.15M | 39.16M | 37.64M | 33.42M | 28.40M | 27.84M | 27.79M | 27.73M | 27.62M | 27.73M | 27.78M | 27.78M | 27.83M | 27.53M | 26.99M | 26.85M | 24.47M | 24.56M | 24.37M | 28.69M | 25.17M | 27.24M | 17.31M | 13.68M | 12.51M | 7.48M | 7.24M |
6%-Yielding National Health Investors: No Pain, No Gain
National Health Investors has had to restructure leases on some troubled tenants to ensure their long-term viability. Recent trends and news point to potential for an industry turnaround in the second half of this year.
Is Now a Good Time to Invest in a Medical REIT?
Medical REITs, down for the past year, may be already in comeback mode.
NHI Announces Fourth Quarter 2022 Earnings Release and Conference Call Date
MURFREESBORO, TN / ACCESSWIRE / January 20, 2023 / National Health Investors, Inc. (NYSE:NHI) announced details for the release of its results for the fourth quarter ended December 31, 2022. NHI plans to issue its earnings release after the market...
5 Most Cheap Real Estate Stocks You Should Think About
The most oversold stocks in the real estate sector presents an opportunity to buy into undervalued companies.
National Health Investors, Inc. (NHI) Q3 2022 Earnings Call Transcript
National Health Investors, Inc. (NYSE:NHI ) Q3 2022 Earnings Conference Call November 9, 2022 12:00 PM ET Company Participants Dana Hambly - VP, Finance & IR Eric Mendelsohn - President & CEO John Spaid - CFO Kevin Pascoe - Chief...
National Health Investors (NHI) Tops Q3 FFO and Revenue Estimates
National Health Investors (NHI) delivered FFO and revenue surprises of 0.95% and 7.97%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Healthcare REITs: Staffing Shortage Stumble
Healthcare REITs have lagged over the past quarter as sharply higher labor costs, a sluggish post-COVID recovery in patient volumes, and the waning of government fiscal support have pressured operators. Hospital operators have been slammed particularly hard as elective surgeries...
NHI Announces Third Quarter 2022 Earnings Release and Conference Call Date
MURFREESBORO, TN / ACCESSWIRE / October 18, 2022 / National Health Investors, Inc. (NYSE:NHI) announced details for the release of its results for the third quarter ended September 30, 2022. NHI plans to issue its earnings release after the market...
7 High-Yield Dividend Stocks to Buy Now
With the world's most powerful central bank committed to a hawkish monetary policy, the narrative for high-yield dividend stocks to buy – which can present fundamental risks – just got much more interesting. Let's get the bad stuff out of...
National Health Investors: Why This 5.5%-Yielding Rebound Is Worth A Shot
NHI has seen its share of ups and downs, and the fundamentals are now looking up. It maintains a very strong balance sheet and pays a well-covered dividend.
Source: https://incomestatements.info
Category: Stock Reports